Tennessee employers are raising concerns with policies being considered in Washington they say would undermine business’ ability to sponsor high-quality and cost-effective prescription drug benefits for their employees.
Read the full story
I have previously written about the disastrous consequences of government mandates in our health care system, specifically pertaining to pharmacy benefit managers (PBMs). Unfortunately, since my piece, there seems to still be a continued push by some lawmakers in Congress to bring misguided policies to fruition. Let’s hope our representatives don’t buy into it.
Read the full story
In Tennessee, the battle to protect pharmacy benefits is not merely a matter of policy, but a battle to protect our country from unnecessary government overreach by the extreme Left. I am deeply troubled by recent attempts at the federal level that target pharmacy benefits and our free market – all in one swoop.
People across our state are already experiencing immense financial strain as they grapple with the soaring costs of inflation and prescriptions, and we need to advocate for policies that will effectively lower these prices through free market competition.
Read the full story
Big Pharma is not your friend. Whether it’s hiking up drug prices or bribing the Swamp, the pharmaceutical industry works against the people’s interests. Many Americans are aware of Big Pharma’s greed and the power it wields over Washington, D.C., but fewer are aware of just how left-wing the industry is. It serves as a cash cow for the left and pushes woke ideas on its employees and the country at large. This may explain why Democrats, who act like they hate Big Pharma, serve the industry’s interests.
While the drugmakers spread their cash around all of DC, they overwhelmingly prefer Democrats. In recent elections, Big Pharma donated significantly more money to Democratic candidates than Republican candidates. From 2016 to 2022, the industry gave a whopping $29 million to Democratic candidates. This trend stands true for the current election cycle, with more cash going to Democrats once again. This favoritism extends to the presidential race. The drug lobby has donated four times more money to Joe Biden than it has to Donald Trump. And the industry’s generosity to Team Blue doesn’t end with individual candidates. Its chief lobby, PhRMA, also gives millions to liberal campaign arms like the Democratic Attorneys General Association.
Read the full story